RCKT ROCKET PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1281895 · EDGAR
- Bought, last 12 months
- $34.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $978.5K 26 sales by 6 insiders
- Filings on record
- 224 since 2021-08-31, latest 2026-09-15 20:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wilson Martin | GC | — | $334.6K |
| Shah Gaurav | CEO, Dir | — | $285.6K |
| Militello John | See Remarks | — | $138.3K |
| Stevens Christopher James | COO | — | $128.3K |
| Chaudhuri Sarbani | See Remarks | — | $84.2K |
| Bjork Elisabeth | Dir | $34.4K | — |
| Schwartz Jonathan David | See Remarks | — | $7,584 |
| Fong Peter | Dir | — | — |
| Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| Malik Fady Ibraham | Dir | — | — |
Transactions 188
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-04 | 2024-10-31 | RCKT | Militello John | See Remarks | S - Sale | $16.63 | -917 | 50.5K | -2% | -$15.2K | |
| 2024-11-04 | 2024-10-31 | RCKT | White Mark Andrew | See Remarks | S - Sale | $16.63 | -3,080 | 69.1K | -4% | -$51.2K | |
| 2024-08-20 | 2024-08-16 | RCKT | Militello John | See Remarks | S - Sale | $18.50 | -1,064 | 51.5K | -2% | -$19.7K | |
| 2024-08-20 | 2024-08-16 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $18.50 | -9,650 | 718.4K | -1% | -$178.5K | |
| 2024-08-20 | 2024-08-16 | RCKT | Wilson Martin | GC | S - Sale | $18.50 | -1,027 | 64.7K | -2% | -$19.0K | |
| 2024-08-20 | 2024-08-16 | RCKT | Patel Kinnari | See Remarks | S - Sale | $18.50 | -3,989 | 397.0K | -1.0% | -$73.8K | |
| 2024-07-24 | 2024-07-22 | RCKT | Militello John | See Remarks | S - Sale | $23.02 | -812 | 52.5K | -2% | -$18.7K | |
| 2024-07-09 | 2024-07-08 | RCKT | White Mark Andrew | See Remarks | S - Sale | $20.40 | -3,026 | 72.2K | -4% | -$61.7K | |
| AI | 2024-06-10 | 2024-03-21 | RCKT | Makker Gotham | Dir | S - Sale | $28.43 | -274.0K | 365.9K | -43% | -$7.79M |
| DM | 2024-05-20 | 2022-08-12+ | RCKT | Wilson Martin | GC | J - Other | $0.00 | +45.7K | 66.8K | +217% | $0 |
| D | 2024-05-20 | 2024-05-16 | RCKT | Wilson Martin | GC | S - Sale+OE | $23.35 | -1,048 | 65.8K | -2% | -$24.5K |
| D | 2024-05-20 | 2024-05-14 | RCKT | Wilson Martin | GC | M - OptEx | $0.00 | +2,420 | 21.1K | +13% | $0 |
| 2024-05-20 | 2024-05-16 | RCKT | Militello John | See Remarks | S - Sale | $23.35 | -1,079 | 53.3K | -2% | -$25.2K | |
| D | 2024-05-20 | 2024-05-16 | RCKT | Patel Kinnari | See Remarks | S - Sale+OE | $23.35 | -4,046 | 401.0K | -1.0% | -$94.5K |
| DM | 2024-05-20 | 2022-02-14+ | RCKT | Patel Kinnari | See Remarks | J - Other | $0.00 | +103.2K | 313.8K | +49% | $0 |
| DM | 2024-05-20 | 2024-05-14 | RCKT | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +9,543 | 296.3K | +3% | $0 |
| DM | 2024-05-20 | 2024-05-14 | RCKT | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +17.7K | 636.5K | +3% | $0 |
| D | 2024-05-20 | 2024-05-16 | RCKT | Shah Gaurav | CEO, Dir | S - Sale+OE | $23.35 | -9,790 | 728.1K | -1% | -$228.6K |
| DM | 2024-05-20 | 2022-02-14+ | RCKT | Shah Gaurav | CEO, Dir | J - Other | $0.00 | +91.7K | 670.1K | +16% | $0 |
| 2024-05-20 | 2024-05-02 | RCKT | SOUTHWELL DAVID P | Dir | G - Gift | $0.00 | -113.1K | 1,660 | -99% | $0 | |
| I | 2024-05-20 | 2024-05-02 | RCKT | SOUTHWELL DAVID P | Dir | G - Gift | $0.00 | -59.7K | 113.1K | -35% | $0 |
| 2024-04-24 | 2024-04-22 | RCKT | Militello John | See Remarks | S - Sale | $22.87 | -833 | 54.4K | -2% | -$19.1K | |
| DM | 2024-04-16 | 2024-04-12+ | RCKT | SOUTHWELL DAVID P | Dir | M - OptEx | $4.34 | +99.6K | 124.8K | +396% | +$432.4K |
| DM | 2024-04-16 | 2024-04-12+ | RCKT | SOUTHWELL DAVID P | Dir | S - Sale+OE | $24.32 | -80.0K | 95.2K | -46% | -$1.95M |
| 2024-04-10 | 2024-04-08 | RCKT | White Mark Andrew | See Remarks | S - Sale | $24.64 | -12.5K | 75.2K | -14% | -$308.8K | |
| D | 2024-04-03 | 2024-04-01 | RCKT | Ondrey Aaron | CFO | A - Grant | $0.00 | +46.8K | 46.8K | New | $0 |
| I | 2024-03-25 | 2024-03-21 | RCKT | Makker Gotham | Dir | S - Sale | $28.43 | -274.0K | 365.9K | -43% | -$7.79M |
| DM | 2024-03-25 | 2022-02-14+ | RCKT | Militello John | See Remarks | J - Other | $0.00 | +36.2K | 46.7K | +347% | $0 |
| D | 2024-03-25 | 2024-03-21 | RCKT | Militello John | See Remarks | S - Sale | $28.10 | -2,490 | 55.2K | -4% | -$70.0K |
| D | 2024-03-04 | 2024-02-29 | RCKT | Militello John | See Remarks | S - Sale+OE | $29.85 | -10.0K | 21.5K | -32% | -$298.5K |
| D | 2024-03-04 | 2024-02-29 | RCKT | Militello John | See Remarks | M - OptEx | $12.55 | +10.0K | 31.5K | +46% | +$125.5K |
| 2024-03-04 | 2024-02-29 | RCKT | Wilson Martin | GC | S - Sale | $29.33 | -4,100 | 18.7K | -18% | -$120.3K | |
| D | 2024-02-21 | 2024-02-16 | RCKT | Wilson Martin | GC | A - Grant | $0.00 | +16.6K | 22.8K | +271% | $0 |
| D | 2024-02-21 | 2024-02-16 | RCKT | Wilson Martin | GC | S - Sale | $29.84 | -3,576 | 6,136 | -37% | -$106.7K |
| D | 2024-02-21 | 2024-02-16 | RCKT | Patel Kinnari | See Remarks | S - Sale | $29.84 | -7,132 | 238.3K | -3% | -$212.8K |
| D | 2024-02-21 | 2024-02-16 | RCKT | Patel Kinnari | See Remarks | A - Grant | $0.00 | +33.3K | 271.6K | +14% | $0 |
| D | 2024-02-21 | 2024-02-16 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $29.84 | -20.3K | 554.8K | -4% | -$604.9K |
| D | 2024-02-21 | 2024-02-16 | RCKT | Shah Gaurav | CEO, Dir | A - Grant | $0.00 | +66.6K | 621.3K | +12% | $0 |
| D | 2024-02-21 | 2024-02-16 | RCKT | Militello John | See Remarks | A - Grant | $0.00 | +8,322 | 21.5K | +63% | $0 |
| D | 2024-02-21 | 2024-02-16 | RCKT | Militello John | See Remarks | S - Sale | $29.84 | -3,238 | 13.2K | -20% | -$96.6K |
| D | 2024-02-21 | 2024-02-16 | RCKT | White Mark Andrew | Chief Medical Off | A - Grant | $0.00 | +11.1K | 87.8K | +14% | $0 |
| D | 2024-02-16 | 2024-02-14 | RCKT | Wilson Martin | GC | M - OptEx | $0.00 | -9,712 | 9,712 | -50% | $0 |
| D | 2024-02-16 | 2024-02-14 | RCKT | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | -46.8K | 575.0K | -8% | $0 |
| D | 2024-02-16 | 2024-02-14 | RCKT | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +26.2K | 245.5K | +12% | $0 |
| D | 2024-02-16 | 2024-02-14 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +6,274 | 16.4K | +62% | $0 |
| 2024-01-23 | 2024-01-22 | RCKT | Militello John | See Remarks | S - Sale | $27.20 | -638 | 10.2K | -6% | -$17.4K | |
| D | 2024-01-22 | 2024-01-18 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +1,586 | 10.8K | +17% | $0 |
| D | 2023-11-16 | 2023-11-14 | RCKT | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,989 | 220.4K | +2% | $0 |
| D | 2023-11-16 | 2023-11-14 | RCKT | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | -7,979 | 532.8K | -1% | $0 |
| D | 2023-11-16 | 2023-11-14 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +725 | 9,485 | +8% | $0 |
| I | 2023-11-16 | 2023-11-15 | RCKT | Makker Gotham | Dir | S - Sale | $22.53 | -20.0K | 1.30M | -2% | -$450.6K |
| 2023-10-25 | 2023-10-20 | RCKT | Militello John | See Remarks | S - Sale | $17.06 | -564 | 8,760 | -6% | -$9,622 | |
| DA | 2023-10-20 | 2023-10-18 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +1,586 | 9,324 | +20% | $0 |
| DA | 2023-10-20 | 2023-02-17 | RCKT | Militello John | See Remarks | S - Sale+OE | $19.06 | -1,076 | 1,782 | -38% | -$20.5K |
| DI | 2023-10-10 | 2023-10-05 | RCKT | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,333 | 101.6K | +3% | $0 |
| MI | 2023-10-02 | 2023-09-28+ | RCKT | Makker Gotham | Dir | S - Sale | $21.06 | -15.0K | 1.32M | -1% | -$315.7K |
| DMI | 2023-08-30 | 2023-08-28 | RCKT | RTW INVESTMENTS, LP | Dir, 10%, See Remarks | J - Other | $18.96 | 0 | 18.66M | New | $0 |
| 2023-08-21 | 2023-08-17 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $15.47 | -4,767 | 524.9K | -0.9% | -$73.7K | |
| 2023-08-21 | 2023-08-17 | RCKT | Patel Kinnari | See Remarks | S - Sale | $15.47 | -1,534 | 216.4K | -0.7% | -$23.7K | |
| 2023-08-21 | 2023-08-17 | RCKT | Militello John | See Remarks | S - Sale | $15.47 | -284 | 5,570 | -5% | -$4,393 | |
| D | 2023-08-15 | 2023-08-14 | RCKT | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +7,979 | 529.6K | +2% | $0 |
| D | 2023-08-15 | 2023-08-14 | RCKT | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,989 | 218.0K | +2% | $0 |
| D | 2023-08-15 | 2023-08-14 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +725 | 7,854 | +10% | $0 |
| 2023-07-24 | 2023-07-20 | RCKT | Militello John | See Remarks | S - Sale | $19.03 | -573 | 7,129 | -7% | -$10.9K | |
| D | 2023-07-20 | 2023-07-18 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +1,586 | 7,702 | +26% | $0 |
| 2023-05-19 | 2023-05-17 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $21.38 | -4,122 | 521.6K | -0.8% | -$88.1K | |
| 2023-05-19 | 2023-05-17 | RCKT | Patel Kinnari | See Remarks | S - Sale | $21.38 | -1,330 | 214.0K | -0.6% | -$28.4K | |
| 2023-05-19 | 2023-05-17 | RCKT | Militello John | See Remarks | S - Sale | $21.38 | -245 | 6,116 | -4% | -$5,238 | |
| D | 2023-05-16 | 2023-05-14 | RCKT | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,989 | 215.3K | +2% | $0 |
| D | 2023-05-16 | 2023-05-14 | RCKT | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +7,979 | 525.8K | +2% | $0 |
| D | 2023-05-16 | 2023-05-14 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +725 | 6,361 | +13% | $0 |
| 2023-04-25 | 2023-04-21 | RCKT | Militello John | See Remarks | S - Sale | $18.65 | -2,342 | 5,636 | -29% | -$43.7K | |
| D | 2023-04-20 | 2023-04-18 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +6,364 | 7,978 | +394% | $0 |
| D | 2023-04-12 | 2023-04-04 | RCKT | White Mark Andrew | Chief Medical Off | A - Grant | $0.00 | +76.7K | 76.7K | New | $0 |
| DI | 2023-04-05 | 2022-12-01 | RCKT | RTW INVESTMENTS, LP | 10%, See Remarks | J - Other | — | +529.0K | 18.16M | +3% | — |
| DA | 2023-02-22 | 2023-02-14 | RCKT | Shah Gaurav | CEO, Dir | M - OptEx | $0.00 | +31.4K | 549.1K | +6% | $0 |
| 2023-02-22 | 2023-02-17 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $19.06 | -12.2K | 536.9K | -2% | -$232.4K | |
| DA | 2023-02-22 | 2023-02-14 | RCKT | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +15.7K | 166.6K | +10% | $0 |
| 2023-02-22 | 2023-02-17 | RCKT | Militello John | See Remarks | S - Sale | $19.06 | -1,244 | 1,614 | -44% | -$23.7K | |
| 2023-02-22 | 2023-02-17 | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $19.06 | -3,557 | 94.5K | -4% | -$67.8K | |
| DA | 2023-02-22 | 2023-02-14 | RCKT | Schwartz Jonathan David | See Remarks | M - OptEx | $0.00 | +8,574 | 98.1K | +10% | $0 |
| DA | 2023-02-22 | 2023-02-14 | RCKT | Militello John | See Remarks | M - OptEx | $0.00 | +2,858 | 2,858 | New | $0 |
| I | 2022-10-11 | 2022-10-06 | RCKT | RTW INVESTMENTS, LP | Dir, 10%, See Remarks | P - Purchase | $14.75 | +1.36M | 17.63M | +8% | +$20.00M |
| MA | 2022-04-04 | 2022-03-30+ | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $16.21 | -135.0K | 170.5K | -44% | -$2.19M |
| M | 2022-04-01 | 2022-03-30 | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $16.41 | -45.0K | 179.5K | -20% | -$738.7K |
| I | 2022-03-09 | 2021-07-27 | RCKT | Makker Gotham | Dir | G - Gift | $0.00 | -621.5K | 674.9K | -48% | $0 |
| 2022-02-08 | 2022-02-07 | RCKT | Shah Gaurav | CEO, Dir | P - Purchase | $17.34 | +22.0K | 517.6K | +4% | +$381.5K | |
| I | 2021-08-31 | 2021-08-27 | RCKT | WONG RODERICK | Dir, 10% | A - Grant | $32.48 | +812.5K | 16.27M | +5% | +$26.39M |
Purchase Sale Sale after option exercise All abbreviations